Credo Technology Group Holding Ltd (CRDO)

Credo Technology Group Holding Ltd (CRDO) is trading in a steep downtrend, with the stock down 40.09% over the past month and 14.03% over the past week. The shares sit 25.76% below their 50-day average and 28.22% below their 200-day average, and the 52-week high of $308.67 is far above the price. Analysts remain strongly positive, with 19 of 20 rating the stock buy or strong buy, while CleaRank's own rating is Hold at 51 out of 100. The gap between Wall Street's enthusiasm and the price action is the central question for the stock now. The pressure has built since the September 1, 2026 report, when the company beat the EPS estimate by 2.56% yet the shares fell 20.04% in the next session. Investors are weighing a strong growth and profitability profile against a valuation that still carries a premium to the sector and a price that has broken well below its recent averages.

The stock has fallen 40.09% over the past month and 47.62% over three months, a move that has taken it from the upper part of its range to the lower part. The 52-week range runs from $86.49 to $308.67, and the stock now sits at 19% of that range.

Return on equity of 30.67% is well above the sector median of 13.4%, and debt-to-equity is 0.01. CleaRank rates the company's health at 5 of 5. These are the strongest figures in the company's recent record, and they explain why analysts remain so positive even after the price fall.

The trailing P/E of 46.00 is 31.1% above the sector median of 35.1, and the price-to-sales ratio of 15.70 is 106.6% above the sector median of 7.6. Over the past 18 months insiders sold stock worth $648.9M across 115 sales and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market buying would, but the absence of insider purchases during the decline is a fact the reader should weigh.

Of 20 analysts with a current rating, 19 rate the stock buy or strong buy and one holds it, with none at sell. Three months ago, 18 of 19 ratings were buy. Rosenblatt kept its Neutral rating on October 15, 2026, and on September 2, 2026, and Stifel kept its Buy rating on October 5, 2026. The consensus is Strong Buy, which is more positive than CleaRank's Hold.

The base case is that CRDO keeps trading as a high-beta stock while it works through the damage of the last two months. With a beta of 3.29 and a typical daily move of 7.00%, large swings in both directions should be expected, and the stock is unlikely to behave calmly in the coming months. A recovery toward the 20-day EMA at $152.79 and then the 50-day SMA at $174.75 would require the trend to stop deteriorating, which means the moving averages must flatten and momentum must improve from its current bearish reading. The case gets worse if sentiment keeps eroding and the price breaks the $86.49 52-week low. The analysts' median 12-month target is $292.00, with a range of $235.00 to $315.00, but those targets are the analysts' forecasts and have not been reached.

Resistance sits first at the 20-day EMA of $152.79, which a rally would meet first. Above it, the 50-day SMA at $174.75 and the 200-day SMA at $180.74 form a cluster that would need to be reclaimed for the trend to change. The 52-week high of $308.67 is the far upside marker. Support is the 52-week low of $86.49, the only level below the price. A fall would meet this first, and it marks the bottom of the stock's one-year range.